New Stock Offerings - Fushun Special Steel (600399) has a tender offer period from August 12, 2025, to September 10, 2025[1] - ST Tianmao (000627) has a cash option declaration period from September 15, 2025, to September 19, 2025[1] - Tianpu Co., Ltd. (605255) announced significant trading activity on September 3, 2025[1] Market Volatility - Kaipu Cloud (688228) reported severe abnormal fluctuations on August 30, 2025[1] - Xinhua Jin (600735) experienced significant trading activity on August 30, 2025[1] - ST Chuntian (600381) had notable trading activity on September 3, 2025[1] Other Notable Announcements - ST Er Ya (600107) reported trading activity on September 3, 2025[1] - Shanghai Electric Power (600021) had significant trading activity on September 3, 2025[1] - ST Gao Hong (000851) reported trading activity on September 3, 2025[1]

相较于大盘股，小市值品种具备更高的股性以及活跃度，也更容易成为行情中的核心。证券时报·数据 宝统计，截至9月2日收盘，两市共994只个股流通市值低于30亿元，其中414只个股流通市值不足20亿 元。总市值方面，两市共1674只个股总市值低于50亿元，其中598只个股总市值不足30亿元。 具体来看，目前两市流通市值最小的前3只股票分别为*ST紫天4.40亿元、博菲电气6.08亿元、鸿铭股份 6.20亿元。总市值最小的前3只股票分别为*ST紫天4.44亿元、*ST元成7.26亿元、*ST苏吴7.75亿元。 （数据宝） 流通市值低于20亿元部分个股一览 | 证券代码 | 证券简称 | 流通市值（亿元） | 总市值（亿元） | 市盈率（倍） | 申万行业 | | --- | --- | --- | --- | --- | --- | | 300280 | *ST紫天 | 4.40 | 4.44 | 39.34 | 传媒 | | 001255 | 博菲电气 | 6.08 | 26.62 | 155.00 | 基础化工 | | 301105 | 鸿铭股份 | 6.20 | 18.84 | - | 机械设备 | | 001 ...

按最新收盘价计算，A股均价为13.38元，不足2元的个股共有31只，股价最低的是*ST高鸿，最新收盘 价为0.93元。 证券时报·数据宝统计显示，截至9月2日收盘，沪指报收3858.13点，A股平均股价为13.38元，从个股股 价分布看，高价股及低价股数量在A股市场总体占比相对较少。 低价股中，股价低于2元的共有31只，最低的是*ST高鸿，最新收盘价为0.93元，其次是*ST苏吴、*ST 金科，最新收盘价分别为1.09元、1.32元。特征来看，股价低于2元个股中，共有13只ST股上榜，占比 为41.94%。 市场表现方面，上述低价股中，今日上涨的有15只，涨幅居前的有雅博股份、*ST苏吴、荣盛发展，分 别上涨6.08%、4.81%、3.40%。下跌的有11只，跌幅居前的有*ST高鸿、*ST京蓝、ST中珠，跌幅分别 为5.10%、1.62%、1.07%。（数据宝） 低价股排名 | 代码 | 简称 | 最新收盘价（元） | 日涨跌幅（%） | 日换手率（%） | 市净率（倍） | 行业 | | --- | --- | --- | --- | --- | --- | --- | | 000851 | *ST高鸿 | ...

Core Viewpoint - *ST Suwu (600200.SH) has experienced significant stock price volatility, with a shift from a limit down to a limit up on September 2, indicating potential irrational speculation and multiple delisting risks [1] Financial Performance - The company reported a net loss attributable to shareholders of 44.42 million yuan for the first half of 2025, a decline of 281.63% compared to the same period last year [1] Regulatory Issues - On July 13, 2025, the company received an administrative penalty notice from the China Securities Regulatory Commission, which identified false records in revenue, costs, and profits in the annual reports from 2020 to 2023, triggering major illegal delisting scenarios [1] Operational Risks - The company faces multiple risks, including significant fund occupation by the controlling shareholder, complete freezing of shares held by the controlling shareholder, and the termination of exclusive agency agreements for medical beauty products, leading to business stagnation [1] Delisting Risks - The company is at risk of financial delisting, par value delisting, and major illegal delisting due to the aforementioned issues [1]

证券代码：600200 证券简称：*ST苏吴 公告编号：临2025-101 江苏吴中医药发展股份有限公司 关于股票交易暨退市风险提示公告 款第（六）项规定的重大违法强制退市情形，可能被实施重大违法强制退市。 公司股票已于 2025 年 7 月 14 日起被叠加实施退市风险警示，如根据中国证 监会正式的处罚决定书结论，公司触及重大违法强制退市情形，公司股票将被终 止上市。请投资者理性投资，注意投资风险。 二、公司存在财务类退市风险 公司 2024 年度财务报告被年审机构出具无法表示意见，触及《上海证券交 易所股票上市规则》第 9.3.2 条第（三）项规定财务类退市的情形，公司股票已 被上海证券交易所实施退市风险警示。具体内容详见公司于 2025 年 4 月 30 日披 露的《关于实施退市风险警示及叠加其他风险警示暨停牌的公告》（公告编号： 临 2025-032）。 三、叠加实施其他风险警示 公司 2024 年度财务报告内部控制被年审机构出具无法表示意见；浙江复基 控股集团有限公司的其他关联方企业存在非经营性占用公司资金的情形。上述事 项触及《上海证券交易所股票上市规则》第 9.8.1 条第（一）（三）项的规定， ...

智通财经APP讯，*ST苏吴(600200.SH)发布公告，公司股票9月2日盘中由跌停至涨停，振幅较大。公司 股票存在多重退市风险，可能存在非理性炒作迹象。敬请广大投资者理性投资、审慎决策，切勿盲目跟 风炒作，避免因公司股价波动造成投资损失。 2025年7月13日，公司收到中国证券监督管理委员会(简称"中国证监会")下发的《行政处罚事先告知 书》(处罚字〔2025〕58号)，认定公司虚增营业收入、营业成本和利润，2020-2023年年度报告存在虚假 记载，触及重大违法强制退市情形。公司目前存在控股股东大额资金占用尚未解决、控股股东所持股份 被全部冻结、医美产品独家代理解约并导致相关业务停滞等多重风险，同时存在财务类退市、面值退市 及重大违法强制退市等多重退市风险。公司2025年半年度业绩亏损。2025年半年度归属于上市公司股东 的净利润-4,441.78万元，比上年同期下降281.63%。请投资者注意投资风险。 ...

New Stock Issuance - Fushun Special Steel (600399) has a tender offer period from August 12, 2025, to September 10, 2025[1] - KaiPu Cloud (688228) reported severe abnormal fluctuations on August 30, 2025[1] - Xinhua Jin (600735) announced on August 30, 2025, regarding its stock activities[1] Trading Alerts - JiShi Media (601929) issued a notice on August 30, 2025, regarding trading activities[1] - XianDao Intelligent (300450) and DeChuang Environmental (603177) both reported updates on September 2, 2025[1] - Huahai Pharmaceutical (600521) and *ST HuiCheng (002168) also provided trading updates on September 2, 2025[1] Abnormal Fluctuations - Several companies, including Changjiang Materials (001296) and WanBangDe (002082), reported abnormal fluctuations on August 28, 2025[3] - Longjing Technology (301396) and Jinli Yongci (300748) also noted significant trading irregularities on August 27, 2025[3] - The report includes multiple links to announcements regarding trading activities and fluctuations for various companies[3]

证券代码：600200 证券简称：*ST苏吴 公告编号：临2025-100 江苏吴中医药发展股份有限公司 股票交易异常波动的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要风险提示： 江苏吴中医药发展股份有限公司（以下简称"公司"）股票连续三个交 易日内收盘价格跌幅偏离值累计超过 12%，属于股票交易异常波动的情形。 2025 年 7 月 13 日，公司收到中国证券监督管理委员会（以下简称"中 国证监会"）下发的《行政处罚事先告知书》（处罚字〔2025〕58 号），具体 内容详见公司于 2025 年 7 月 14 日披露的《关于收到中国证券监督管理委员会< 行政处罚事先告知书>的公告》（公告编号：临 2025-064）。公司股票已于 2025 年 7 月 14 日起被叠加实施退市风险警示，如根据中国证监会正式的处罚决定书 结论，公司触及重大违法强制退市情形，公司股票将被终止上市。敬请广大投资 者关注后续公告并注意投资风险。 公司 2024 年度财务报告被年审机构出具无法表示意见，触及《上海证券 交易所股票上市规则》第 ...

Group 1 - The stock exchange monitors trading behavior of stocks that exhibit significant abnormal fluctuations within 10 trading days after such events occur, particularly focusing on large buy or sell orders within a one-minute timeframe [1] Group 2 - A list of stocks under abnormal fluctuation monitoring includes: - Kaipu Cloud: Monitoring from September 1, 2025, to September 12, 2025, with abnormal activity starting on August 25, 2025 - *ST Gao Hong: Monitoring from August 26, 2025, to September 8, 2025, with undisclosed abnormal activity start date - Siquan New Materials: Monitoring from August 22, 2025, to September 4, 2025, with undisclosed abnormal activity start date - *ST Su Wu: Monitoring from August 21, 2025, to September 3, 2025, with undisclosed abnormal activity start date - Sano Medical: Monitoring from August 19, 2025, to September 1, 2025, with abnormal activity starting on August 7, 2025 [2][3]

Core Viewpoint - *ST Suwu has experienced a significant decline in both revenue and net profit in the first half of 2025, primarily due to a substantial impairment provision for trade receivables, despite high growth in its medical beauty segment. The loss of exclusive distribution rights for its key product, AestheFill, poses a serious challenge for the company's future performance [2][3][7]. Financial Performance - In the first half of 2025, *ST Suwu reported revenue of 636 million yuan, a year-on-year decrease of 27.08% [3]. - The net profit attributable to shareholders was a loss of 44.42 million yuan, a decline of 281.63% compared to the previous year [3]. - The operating cash flow was negative at -885 million yuan, down 680.0% year-on-year [3]. - Basic earnings per share stood at -0.062 yuan [3]. Business Segment Analysis - The pharmaceutical business, as the traditional core segment, generated revenue of 358.10 million yuan, a decline of 53.81% year-on-year [4]. - The medical beauty segment achieved revenue of 268.19 million yuan, a remarkable increase of 234.73% year-on-year [5]. - The gross profit from the pharmaceutical segment was 184.66 million yuan, down 32.09% year-on-year, while the medical beauty segment's gross profit was 220.44 million yuan, up 231.94% year-on-year [5]. Key Product and Market Changes - The exclusive distribution rights for AestheFill were unilaterally terminated by Regen Biotech, which poses a significant risk to *ST Suwu's revenue stream [7]. - The termination was attributed to alleged violations of the distribution agreement and financial misconduct by *ST Suwu [7][8]. - The product AestheFill will be rebranded as "Zhen Ai Su Fei" in the Chinese market, further complicating *ST Suwu's ability to maintain its market position [8]. Stock Market Activity - Despite the declining performance and potential delisting risks, *ST Suwu's stock has seen unusual trading activity, with significant price increases observed in late August 2025 [8][9]. - The stock price fluctuated, with a notable drop of 1.71% and 5.22% on August 28 and 29, respectively, bringing it close to the warning line of 1 yuan [9].